Effects of MS-31-038, a novel Na+-H+ exchange inhibitor, on the myocardial infarct size in rats after postischemic administration

Arzneimittel-Forschung/Drug Research

Volumn 49, Issue 4, 1999, Pages 304-310

  Banno, Hitoshi ^a   Fujiwara, Junya ^b   Hosoya, Junko ^a   Kitamori, Takashi ^a   Mori, Haruki ^b   Yamashita, Hiroyuki ^b   Ikeda, Fumiaki ^a  

^a Mitsui Pharmaceuticals Inc   (Japan)

^b MITSUI CHEMICALS INC   (Japan)

Author keywords

2 (2 Methylphenyl) 5,7 dimethoxy 4 quinolyl carbonylguanidine dihydrochloride; 2 Phenyl 8 (2 methoxyethoxy) 4 quinolyl carbonylguanidine bismethanesulfonate; CAS 181048 29 3; CAS 181048 36 2; Ischemia; MS 31 038, effect on myocardial infarct size, rat; Na+ H+ exchange; Reperfusion arrhythmia

Indexed keywords

2 (2 METHYLPHENYL) 5,7 DIMETHOXY 4 QUINOLYLCARBONYLGUANIDINE DIHYDROCHLORIDE; 2 PHENYL 8 (2 METHOXYETHOXY) 4 QUINOLYLCARBONYLGUANIDINE BISMETHANESULFONATE; ANTIARRHYTHMIC AGENT; CARIPORIDE; PROTON; SODIUM ION; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART ARRHYTHMIA; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INTRAVENOUS DRUG ADMINISTRATION; ION EXCHANGE; MALE; MEASUREMENT; NONHUMAN; RAT; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY;

EID: 0037599092     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300419     Document Type: Article

References (30)

1. [1] Mahnensmith, R. L., Aroson, P. S., Circ. Res. 57, 773 (1985)
2. [2] Noel, J., Pouyssegur, A., Am. J. Physiol. 268, C283 (1995)
3. [3] Murphy, E., Perlman, M., London, R. E., Circ. Res. 68, 1250 (1991)
4. [4] Pike, M. M., Luo, C. S., Clark, M. D., Am. J. Physiol. 265, H2017 (1993)
5. [5] Dennis, S. D., Coetzee, W. A., Cragoe, Jr. E. J., Circ. Res. 66, 1156 (1990)
6. [6] Scholz, W., Albus, U., Lang, H. J., Br. J. Pharmacol. 109, 562 (1993)
7. [7] Sack, S., Mori, Z. M., Schwarz, E. R., J. Cardiovasc. Pharmacol. 23, 72 (1994)
8. [8] Yasutake, M., Ibuki, C., Herase, D. J., Am. J. Physiol. 267, H2430 (1994)
9. [9] Xue, Y. X., Aye, N. N., Hashimoto, K., Eur. J. Pharmacol. 317, 309 (1996)
10. [10] Aye, N. N., Xue, Y. X., Hashimoto, K., Eur. J. Pharmacol. 339, 121 (1997)
11. [11] Rohmann, S., Weygandt, H., Minck, K. O., Cardiovasc. Res. 30, 945 (1995)
12. [12] Klein, H. H., Pich, S., Bohle, R. M., Circulation 92, 912 (1995)
13. [13] Klein, H. H., Bohle, R. M., Pich, S., J. Cardiovasc. Pharmacol. 30, 235 (1997)
14. [14] Counillon, L., Scholz, W., Lang, H. J., Mol. Pharmacol. 44, 1041 (1993)
15. [15] Scholz, W., Albus, U., Counillon, L., Cardiovasc. Res. 29, 260 (1995)
16. [16] Miura, T., Ogawa, T., Suzuki, K., J. Am. Coll. Cardiol. 29, 693 (1997)
17. [17] Foster, C. D., Hill, W. A. G., Honeyman, T. W., Am. J. Physiol. 262, H1651 (1992)
18. [18] Raya, T. H., Gaballa, M., Anderson, P., Am. J. Physiol. 273, H2652 (1997)
19. [19] Walker, M. J. A., Curtis, M. J., Hearse, D. J., Cardiovasc. Res. 22, 447 (1988)
20. [20] Neylon, C. B., Little, P. J., Cragoe, Jr., Circ. Res. 67, 814 (1990)
21. [21] Karmazyn, M., Am. J. Physiol. 255, H608 (1988)
22. [22] Vanderberg, J. I., Metcalfe, J. C., Grace, A. A., Circ. Res. 72, 993 (1993)
23. [23] Ladilov, Y. V., Siegmund, B., Piper, H. M., Am. J. Physiol. 268, H1531 (1995)
24. [24] Siegmund, B., Zude, R., Piper, H. M., Am. J. Physiol. 263, H1262 (1992)
25. [25] Vaughan Williams, E. M. (ed.), Handbook of Experimental Pharmacology, Vol. 89, pp. 201-233, Springer-Verlag, New York (1989)
26. [26] Leyssens, A., Carmeliet, E., Eur. J. Pharmacol. 196, 43 (1991)
27. [27] Meszaros, J., Pappano, A. J., Am. J. Physiol. 258, H931 (1990)
28. [28] Maxwell, M. P., Hearse, D. J., Yellon, D. M., J. Moll. Cell Cardiol. 16 (Suppl. 2), 22p (1984)
29. [29] Fliegel, L., Dyck, J. R. B., Wang, H., Mol. Cell. Biochem. 125, 137 (1993)
30. [30] Dyck, J. R. B., Maddaford, T. G., Pierce, G. N., Cardiovasc. Res. 29, 203 (1995)